JOSEPH C PAPA
CIK 1242215 · President and CEO · last filed 2026-05-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.59M
Companies
7
Total Filings
104
Lifetime Open-Market Net
-$40.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EBS | President and CEO | 493,153 | $8.32 | $4.10M | $349.8K | 6 | 2026-05-01 |
| CADL | Director | 102,271 | $8.56 | $875.4K | $73.1K | 7 | 2026-04-02 |
| MIST | Director | 100,000 | $1.27 | $127.0K | $0 | 3 | 2025-07-15 |
| Prometheus Biosciences, Inc. (RXDX) Delisted | Director | 0 | $199.92 | $0 | $285.0K | 6 | 2023-06-16 |
| BHC | CHAIRMAN & CEO | 1,395,371 | $5.06 | $7.06M | $2.08M | 18 | 2022-05-12 |
| BLCO | CEO & Chairman | 472,222 | $15.08 | $7.12M | $0 | 1 | 2022-05-09 |
| PRGO | CEO | 118,515 | $10.99 | $1.30M | -$43.21M | 58 | 2016-03-01 |
Recent Filings · Page 2 of 11
104 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-05 | MIST | Grant (A) | — | $0 | EDGAR |
| 2024-06-27 | CADL | Grant (A) | — | $0 | EDGAR |
| 2024-03-15 | EBS | Grant (A) | — | $0 | EDGAR |
| 2023-06-29 | CADL | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | Prometheus Biosciences, Inc. (RXDX) Delisted | Disp (D) | −17,278 | $0 | EDGAR |
| 2023-06-02 | Prometheus Biosciences, Inc. (RXDX) Delisted | Other (J) | — | $0 | EDGAR |
| 2023-05-19 | Prometheus Biosciences, Inc. (RXDX) Delisted | Grant (A) | +2,278 | $0 | EDGAR |
| 2022-12-12 | CADL | Buy (P) | +38,032 | $73.1K | EDGAR |
| 2022-08-10 | CADL | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | Prometheus Biosciences, Inc. (RXDX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.